DoD/CDMRP - COVID-19 Impact on Research Awards

See important announcement below from the Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). They are stressing the importance of disclosing significant developments impacting research awards, including problems, delays and other events impacting your ability to meet the award objectives.

As always, please reach out to your SPA Project Officer should you have questions or concerns about your awards.

CDMRP continues to be concerned about the impacts of COVID-19 on Service Members and the public.  We are aware of the challenges it poses and are tracking some of the impacts to current awardees and ongoing research.  While not every program will have financial resources available to assist, awareness of any significant unresolved issues affecting current research awards is important.

The intent of this notice is to remind recipients of the requirements in 32 CFR Part 1134, Subpart E Other Reporting. This provision specifies the requirement for recipients to disclose significant developments as soon as they become known.  These include problems, delays, or adverse conditions that will materially impair your ability to meet the objectives of your awards.

Disclosures of significant developments may be made on your next interim performance report or at any point between scheduled performance reporting dates by contacting the Science Officer or Grant Specialist assigned to your award. This disclosure must include a statement of the action taken, or contemplated, and any assistance needed to resolve the situation.

For questions concerning this notice, please contact the Grants Specialist and Science Officer or Grants Officer’s Representative listed in your award.